Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Medical Genetics · Galactosemia

Decoding the Lab Results: Classic vs. Duarte Galactosemia

At a Glance

Newborn screening for galactosemia flags both the severe Classic form and the milder Duarte variant. Classic galactosemia involves less than 1% GALT enzyme activity and requires a strict lactose-free diet. Duarte galactosemia has about 25% activity and typically requires no dietary changes.

Receiving a positive newborn screening (NBS) result can be a confusing and frightening experience. It is important to know that the NBS is just a “flag”—it tells doctors that more specialized testing is needed to confirm if a baby truly has galactosemia or if they have a milder version that may not require treatment [1][2].

Understanding “Erythrocyte GALT Enzyme Activity”

When doctors look for galactosemia, they test your baby’s erythrocytes (red blood cells) for an enzyme called GALT. Think of GALT as a key that unlocks the door to processing milk sugar.

On a lab report, this is often listed as GALT enzyme activity [3]. The result tells you how many “keys” your baby has working:

  • Classic Galactosemia (G/G): Most babies with the classic form have less than 1% of normal GALT activity [4][5]. Their body has almost no “keys” to process milk sugar, making a strict, life-long diet essential [6].
  • Duarte Galactosemia (D/G): Babies with the Duarte variant usually have about 25% of normal GALT activity [3][5]. They have enough “keys” to handle most or all of the galactose they consume [7].

Genetic Testing: The Q188R and N314D Markers

While enzyme tests tell us how much the “keys” are working, genetic testing looks at the “blueprints” (the DNA) for those keys. This helps confirm the diagnosis and can sometimes help doctors predict the severity of the condition [8][6].

  • Q188R: This is a common mutation associated with Classic Galactosemia [6]. If a baby has two copies (G/G), they will have the classic, severe form [4].
  • N314D: This mutation is the hallmark of the Duarte variant. It causes the enzyme to be less stable, resulting in lower activity but not a total loss [6].

Classic vs. Duarte: The Clinical Difference

The most important distinction for parents is how these two diagnoses are managed.

Feature Classic Galactosemia (G/G) Duarte Galactosemia (D/G)
Enzyme Activity < 1% (Severely deficient) [4] ~25% (Partial deficiency) [3]
NBS Result Very high Gal-1-P; Very low GALT [9] Mildly high Gal-1-P; Low GALT [1]
Management Strict lactose-free/soy diet required [10] No diet typically required [7]
Risks High risk of acute illness if untreated [6] No increased risk of illness or delays [11]

Current medical consensus shows that infants with Duarte Galactosemia do not experience the same health risks as those with the Classic form [7][12]. Research indicates that they can be fed milk or standard formula without any negative effects on their development [13][11].

Your Lab Report Completeness Checklist

When you receive your child’s lab reports, ensure you have these three specific data points. Having all three allows your specialist to give you the most accurate diagnosis:

  1. GALT Enzyme Activity: Usually expressed as a number (e.g., μmol/h/gHb\mu \text{mol/h/gHb}) or a percentage of the “normal” range [3].
  2. Galactose-1-Phosphate (Gal-1-P): This measures the “toxic buildup” in the blood. In Classic cases, this is very high at diagnosis [14].
  3. Molecular Genotype: This identifies the specific DNA mutations (like Q188R or N314D) to confirm if the condition is Classic, Duarte, or a carrier state [8].

If any of these are missing, ask your doctor or genetic counselor to help you obtain the full report.

Common questions in this guide

What is the difference between Classic and Duarte galactosemia?
Classic galactosemia is a severe condition where the body has almost no GALT enzyme activity, requiring a strict lifelong lactose-free diet. Duarte galactosemia is a milder variant with about 25% enzyme activity and typically does not require dietary restrictions.
What does GALT enzyme activity mean on my baby's lab report?
GALT enzyme activity measures how well your baby's red blood cells can process milk sugar. Babies with Classic galactosemia usually have less than 1% activity, while those with the Duarte variant have enough activity to safely consume standard breast milk or formula.
Do babies with Duarte galactosemia need a soy-based diet?
Current medical consensus indicates that infants with Duarte galactosemia do not require a special diet. They can usually consume breast milk or standard formula without negative health or developmental effects.
What are the Q188R and N314D genetic mutations?
These are DNA blueprints that help doctors confirm the diagnosis. Q188R is a common mutation that causes severe Classic galactosemia when a baby has two copies. N314D is the hallmark mutation for the milder Duarte variant.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was my baby’s exact GALT enzyme activity percentage compared to a healthy control?
  2. 2.Are the genetic results 'G/G' (Classic), 'D/G' (Duarte), or something else?
  3. 3.Based on these lab results, does my baby need to be on a strict soy-based diet, or can we continue breastfeeding/cow-milk formula?
  4. 4.Does our specific genetic mutation (like Q188R) tell us anything more about what to expect?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Addition of galactose-1-phosphate measurement enhances newborn screening for classical galactosemia.

    Daas S, Abu Salah N, Anikster Y, et al.

    Journal of inherited metabolic disease 2023; (46(2)):232-242 doi:10.1002/jimd.12580.

    PMID: 36515074
  2. 2

    Including Classical Galactosaemia in the Expanded Newborn Screening Panel Using Tandem Mass Spectrometry for Galactose-1-Phosphate.

    Cohen AS, Baurek M, Lund AM, et al.

    International journal of neonatal screening 2019; (5(2)):19 doi:10.3390/ijns5020019.

    PMID: 33072978
  3. 3

    Galactose-1-Phosphate Uridyltransferase Activities in Different Genotypes: A Retrospective Analysis of 927 Samples.

    Yuzyuk T, Wilson AR, Mao R, Pasquali M

    The journal of applied laboratory medicine 2018; (3(2)):222-230 doi:10.1373/jalm.2017.025536.

    PMID: 33636947
  4. 4

    Transient developmental delays in infants with Duarte-2 variant galactosemia.

    Waisbren SE, Tran C, Demirbas D, et al.

    Molecular genetics and metabolism 2021; (134(1-2)):132-138 doi:10.1016/j.ymgme.2021.07.009.

    PMID: 34391645
  5. 5

    The natural history of classic galactosemia: lessons from the GalNet registry.

    Rubio-Gozalbo ME, Haskovic M, Bosch AM, et al.

    Orphanet journal of rare diseases 2019; (14(1)):86 doi:10.1186/s13023-019-1047-z.

    PMID: 31029175
  6. 6

    Galactosemia.

    Cerone J, Rios A

    Pediatrics in review 2019; (40(Suppl 1)):24-27 doi:10.1542/pir.2018-0150.

    PMID: 31575690
  7. 7

    Answering a Question Older Than Most Pediatricians: What to Do About Duarte Variant Galactosemia.

    McCandless SE

    Pediatrics 2019; (143(1)) doi:10.1542/peds.2018-3292.

    PMID: 30593448
  8. 8

    Twelve-year review of galactosemia newborn screening in Taiwan: Evolving methods and insights.

    Chen HA, Hsu RH, Chen LC, et al.

    Molecular genetics and metabolism reports 2024; (38()):101048 doi:10.1016/j.ymgmr.2024.101048.

    PMID: 38469088
  9. 9

    All aspects of galactosemia: a single center experience.

    Akgun A, Dogan Y

    Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(1)):29-35 doi:10.1515/jpem-2022-0308.

    PMID: 36399011
  10. 10

    Screening for galactosemia: is there a place for it?

    Kotb MA, Mansour L, Shamma RA

    International journal of general medicine 2019; (12()):193-205 doi:10.2147/IJGM.S180706.

    PMID: 31213878
  11. 11

    RE: Commentary on Developmental Outcomes in Duarte Galactosemia.

    Feder SL

    Pediatrics 2019; (143(5)) doi:10.1542/peds.2019-0477.

    PMID: 31040192
  12. 12

    Developmental Outcomes in Duarte Galactosemia.

    Carlock G, Fischer ST, Lynch ME, et al.

    Pediatrics 2019; (143(1)) doi:10.1542/peds.2018-2516.

    PMID: 30593450
  13. 13

    Acute and early developmental outcomes of children with Duarte galactosemia.

    Fridovich-Keil JL, Carlock G, Patel S, et al.

    JIMD reports 2022; (63(1)):101-106 doi:10.1002/jmd2.12267.

    PMID: 35028275
  14. 14

    Effect of genotype on galactose-1-phosphate in classic galactosemia patients.

    Yuzyuk T, Balakrishnan B, Schwarz EL, et al.

    Molecular genetics and metabolism 2018; (125(3)):258-265 doi:10.1016/j.ymgme.2018.08.012.

    PMID: 30172461

This page explains galactosemia lab results for educational purposes only and does not replace professional medical advice. Always consult your pediatrician or genetic counselor for an official interpretation of your baby's newborn screening and lab reports.

Get notified when new evidence is published on Classic galactosemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.